Effectiveness of adjuvant traditional Chinese medicine on macrovascular invasion in patients with hepatocellular carcinoma: a real-world propensity score-matched study.

Authors:
Yan H; Wang X; Yu L; Liu X; Yan F and 3 more

Journal:
Front Pharmacol

Publication Year: 2024

DOI:
10.3389/fphar.2024.1353720

PMCID:
PMC10923102

PMID:
38464727

Journal Information

Journal Title: Front Pharmacol

Detailed journal information not available.

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Funding for this research was made possible thanks to grants from the National Natural Science Foundation of China (grant no. 82274479), the Special Fund of Capital Health Research and Development (grant no. 2020-2-2173), High-level Public Health Technical Personnel Construction Project(Subject leaders-02-16), the Beijing Hospitals Authority Clinical Medicine Development of Special Funding (grant no. ZYLX202127), and the Dengfeng Talent Support Program of Beijing Municipal Administration of Hospitals (grant no. DFL20191803)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025